XML 49 R37.htm IDEA: XBRL DOCUMENT
v3.19.2

Segment Information (Details) $ in Thousands | 3 Months Ended | 6 Months Ended |
--- | --- | --- | ---
Jun. 30, 2019 USD ($) segment | Mar. 31, 2019 segment | Jun. 30, 2018 USD ($) | Jun. 30, 2019 USD ($) segment | Jun. 30, 2018 USD ($) | Dec. 31, 2018 USD ($)
Segment information |  |  |  |  |  |
Number of business segments | segment | 4 |  |  | 4 |  |
Net sales: |  |  |  |  |  |
Total net sales revenue | $ 90,724 |  | $ 91,266 | $ 181,996 | $ 178,608 |
Contribution margin: |  |  |  |  |  |
Total contribution margin | 35,557 |  | 35,496 | 72,387 | 68,763 |
Selling, general and administrative expenses | 31,019 |  | 33,310 | 64,871 | 65,696 |
Operating income | 4,538 |  | 2,186 | 7,516 | 3,067 |
Other income (loss), net | 306 |  | (1,807) | 258 | (1,067) |
Income before provision for income taxes | 4,844 |  | 379 | 7,774 | 2,000 |
Total property, plant and equipment | 61,911 |  |  | 61,911 |  | $ 64,061
Total assets | 216,251 |  |  | 216,251 |  | 193,016
NSP Americas; NSP Russia, Central and Eastern Europe; and NSP China |  |  |  |  |  |
Segment information |  |  |  |  |  |
Number of operating segments | segment |  | 3 |  |  |  |
Synergy WorldWide |  |  |  |  |  |
Segment information |  |  |  |  |  |
Number of operating segments | segment |  | 1 |  |  |  |
Asia |  |  |  |  |  |
Net sales: |  |  |  |  |  |
Total net sales revenue | 35,162 |  | 35,767 | 68,758 | 63,530 |
Contribution margin: |  |  |  |  |  |
Total contribution margin | 16,291 |  | 17,275 | 32,402 | 29,641 |
Total assets | 72,752 |  |  | 72,752 |  | 59,983
Asia | General health |  |  |  |  |  |
Net sales: |  |  |  |  |  |
Total net sales revenue | 10,752 |  | 8,519 | 18,836 | 14,753 |
Asia | Immune |  |  |  |  |  |
Net sales: |  |  |  |  |  |
Total net sales revenue | 199 |  | 133 | 357 | 434 |
Asia | Cardiovascular |  |  |  |  |  |
Net sales: |  |  |  |  |  |
Total net sales revenue | 11,561 |  | 13,496 | 23,394 | 23,398 |
Asia | Digestive |  |  |  |  |  |
Net sales: |  |  |  |  |  |
Total net sales revenue | 7,333 |  | 6,274 | 12,108 | 11,698 |
Asia | Personal care |  |  |  |  |  |
Net sales: |  |  |  |  |  |
Total net sales revenue | 1,820 |  | 3,086 | 6,087 | 5,268 |
Asia | Weight management |  |  |  |  |  |
Net sales: |  |  |  |  |  |
Total net sales revenue | 3,497 |  | 4,259 | 7,976 | 7,979 |
Europe |  |  |  |  |  |
Net sales: |  |  |  |  |  |
Total net sales revenue | 15,075 |  | 13,922 | 30,672 | 28,525 |
Contribution margin: |  |  |  |  |  |
Total contribution margin | 4,822 |  | 4,648 | 9,827 | 9,709 |
Total assets | 17,683 |  |  | 17,683 |  | 16,414
Europe | General health |  |  |  |  |  |
Net sales: |  |  |  |  |  |
Total net sales revenue | 5,372 |  | 5,424 | 11,120 | 10,928 |
Europe | Immune |  |  |  |  |  |
Net sales: |  |  |  |  |  |
Total net sales revenue | 1,090 |  | 832 | 2,363 | 1,776 |
Europe | Cardiovascular |  |  |  |  |  |
Net sales: |  |  |  |  |  |
Total net sales revenue | 2,766 |  | 2,806 | 5,617 | 5,863 |
Europe | Digestive |  |  |  |  |  |
Net sales: |  |  |  |  |  |
Total net sales revenue | 3,550 |  | 3,134 | 7,181 | 6,362 |
Europe | Personal care |  |  |  |  |  |
Net sales: |  |  |  |  |  |
Total net sales revenue | 1,661 |  | 1,048 | 3,160 | 2,211 |
Europe | Weight management |  |  |  |  |  |
Net sales: |  |  |  |  |  |
Total net sales revenue | 636 |  | 678 | 1,231 | 1,385 |
North America |  |  |  |  |  |
Net sales: |  |  |  |  |  |
Total net sales revenue | 34,620 |  | 35,518 | 71,143 | 73,623 |
Contribution margin: |  |  |  |  |  |
Total contribution margin | 12,026 |  | 11,180 | 25,418 | 24,592 |
Total assets | 117,182 |  |  | 117,182 |  | 109,091
North America | General health |  |  |  |  |  |
Net sales: |  |  |  |  |  |
Total net sales revenue | 14,934 |  | 15,731 | 30,682 | 31,830 |
North America | Immune |  |  |  |  |  |
Net sales: |  |  |  |  |  |
Total net sales revenue | 3,340 |  | 3,344 | 7,558 | 8,279 |
North America | Cardiovascular |  |  |  |  |  |
Net sales: |  |  |  |  |  |
Total net sales revenue | 4,935 |  | 4,870 | 10,011 | 9,671 |
North America | Digestive |  |  |  |  |  |
Net sales: |  |  |  |  |  |
Total net sales revenue | 8,523 |  | 8,521 | 17,244 | 17,497 |
North America | Personal care |  |  |  |  |  |
Net sales: |  |  |  |  |  |
Total net sales revenue | 1,598 |  | 1,268 | 2,946 | 2,843 |
North America | Weight management |  |  |  |  |  |
Net sales: |  |  |  |  |  |
Total net sales revenue | 1,290 |  | 1,784 | 2,702 | 3,503 |
Latin America and Other |  |  |  |  |  |
Net sales: |  |  |  |  |  |
Total net sales revenue | 5,867 |  | 6,059 | 11,423 | 12,930 |
Contribution margin: |  |  |  |  |  |
Total contribution margin | 2,418 |  | 2,393 | 4,740 | 4,821 |
Total assets | 8,634 |  |  | 8,634 |  | 7,528
Latin America and Other | General health |  |  |  |  |  |
Net sales: |  |  |  |  |  |
Total net sales revenue | 1,783 |  | 1,794 | 3,395 | 3,878 |
Latin America and Other | Immune |  |  |  |  |  |
Net sales: |  |  |  |  |  |
Total net sales revenue | 602 |  | 567 | 1,210 | 1,267 |
Latin America and Other | Cardiovascular |  |  |  |  |  |
Net sales: |  |  |  |  |  |
Total net sales revenue | 361 |  | 288 | 700 | 766 |
Latin America and Other | Digestive |  |  |  |  |  |
Net sales: |  |  |  |  |  |
Total net sales revenue | 2,645 |  | 2,931 | 5,181 | 5,883 |
Latin America and Other | Personal care |  |  |  |  |  |
Net sales: |  |  |  |  |  |
Total net sales revenue | 260 |  | 302 | 517 | 613 |
Latin America and Other | Weight management |  |  |  |  |  |
Net sales: |  |  |  |  |  |
Total net sales revenue | 216 |  | 177 | 420 | 523 |
CHINA |  |  |  |  |  |
Contribution margin: |  |  |  |  |  |
Selling, general and administrative expenses | 2,300 |  | 2,500 | 4,500 | 4,000 |
United States |  |  |  |  |  |
Net sales: |  |  |  |  |  |
Total net sales revenue | 32,194 |  | 32,914 | 66,155 | 68,140 |
Contribution margin: |  |  |  |  |  |
Total property, plant and equipment | 57,608 |  |  | 57,608 |  | 60,606
South Korea |  |  |  |  |  |
Net sales: |  |  |  |  |  |
Total net sales revenue | 18,923 |  | 19,608 | 37,451 | 34,192 |
Other |  |  |  |  |  |
Net sales: |  |  |  |  |  |
Total net sales revenue | 39,607 |  | $ 38,744 | 78,390 | $ 76,276 |
Other |  |  |  |  |  |
Contribution margin: |  |  |  |  |  |
Total property, plant and equipment | $ 4,303 |  |  | $ 4,303 |  | $ 3,455

X
- Definition Represents the amount of contribution margin which consists of net sales revenue less cost of sales and volume incentives expense. + References No definition available. + Details
Name: | natr_ContributionMargin
Namespace Prefix: | natr_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- References No definition available. + Details
Name: | natr_ContributionMarginAbstract
Namespace Prefix: | natr_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 942 -SubTopic 210 -Section S99 -Paragraph 1 -Subparagraph (SX 210.9-03(11)) -URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 22 -URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 944 -SubTopic 210 -Section S99 -Paragraph 1 -Subparagraph (SX 210.7-03(a)(12)) -URI http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910 + Details
Name: | us-gaap_Assets
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08.(h)(1)(i)) -URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690 + Details
Name: | us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues. + References No definition available. + Details
Name: | us-gaap_NumberOfOperatingSegments
Namespace Prefix: | us-gaap_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | duration

X
- Definition Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements. + References No definition available. + Details
Name: | us-gaap_NumberOfReportableSegments
Namespace Prefix: | us-gaap_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | duration

X
- Definition The net result for the period of deducting operating expenses from operating revenues. + References No definition available. + Details
Name: | us-gaap_OperatingIncomeLoss
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Amount of income (expense) related to nonoperating activities, classified as other. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 220 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.9) -URI http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227 + Details
Name: | us-gaap_OtherNonoperatingIncomeExpense
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(14)) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 360 -SubTopic 10 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 944 -SubTopic 210 -Section S99 -Paragraph 1 -Subparagraph (SX 210.7-03(a)(8)) -URI http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910 Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(13)) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 + Details
Name: | us-gaap_PropertyPlantAndEquipmentNet
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 606 -SubTopic 10 -Section 50 -Paragraph 4 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=118956577&loc=SL49130543-203045 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 606 -SubTopic 10 -Section 50 -Paragraph 5 -URI http://asc.fasb.org/extlink&oid=118956577&loc=SL49130545-203045 + Details
Name: | us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References No definition available. + Details
Name: | us-gaap_SegmentReportingInformationLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_SegmentReportingInformationRevenueAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 330 -SubTopic 10 -Section 30 -Paragraph 8 -URI http://asc.fasb.org/extlink&oid=68048583&loc=d3e3636-108311 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 220 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.4) -URI http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227 + Details
Name: | us-gaap_SellingGeneralAndAdministrativeExpense
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Details
Name: | us-gaap_StatementBusinessSegmentsAxis=natr_NSPAmericasNSPRussiaCentralandEasternEuropeandNSPChinaMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementBusinessSegmentsAxis=natr_SynergyWorldWideMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementBusinessSegmentsAxis=natr_AsiaSegmentMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=natr_GeneralHealthProductsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=natr_ImmunityProductsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=natr_CardiovascularProductsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=natr_DigestiveProductsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=natr_PersonalCareProductsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=natr_WeightManagementProductsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementBusinessSegmentsAxis=natr_EuropeSegmentMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementBusinessSegmentsAxis=natr_NorthAmericaSegmentMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementBusinessSegmentsAxis=natr_LatinAmericaAndOtherSegmentMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_StatementGeographicalAxis=country_CN
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_StatementGeographicalAxis=country_US
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_StatementGeographicalAxis=country_KR
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_StatementGeographicalAxis=natr_OtherCountriesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_StatementGeographicalAxis=us-gaap_NonUsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |